Related Experiment Video
Updated: Oct 12, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
A Combination of M50I and V151I Polymorphic Mutations in HIV-1 Subtype B Integrase Results in Defects in
Jun Yang1, Ming Hao1, Muhammad A Khan2
1Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, MD 21702, USA.
Abstract:
We have recently reported that a recombinant HIV-1NL4.3 containing Met-to-Ile change at codon 50 of integrase (IN) (IN:M50I) exhibits suppression of the virus release below 0.5% of WT HIV, and the released viral particles are replication-incompetent due to defects in Gag/GagPol processing by inhibition of the initiation of autoprocessing of GagPol polyproteins in the virions and leads to replication-incompetent viruses. The coexisting Ser-to-Asn change at codon 17 of IN or Asn-to-Ser mutation at codon 79 of RNaseH (RH) compensated the defective IN:M50I phenotype, suggesting that both IN and RH regulate an HIV infectability. In the current study, to elucidate a distribution of the three mutations during anti-retroviral therapy among patients, we performed a population analysis using 529 plasma virus RNA sequences obtained through the MiSeq. The result demonstrated that 14 plasma HIVs contained IN:M50I without the compensatory mutations. Comparing the sequences of the 14 viruses with that of the defective virus illustrated that only Val-to-Ile change at codon 151 of IN (IN:V151I) existed in the recombinant virus. This IN:V151I is known as a polymorphic mutation and was derived from HIVNL4.3 backbone. A back-mutation at 151 from Ile-to-Val in the defective virus recovered HIV replication capability, and Western Blotting assay displayed that the back-mutation restored Gag/GagPol processing in viral particles. These results demonstrate that a combination of IN:M50I and IN:V151I mutations, but not IN:M50I alone, produces a defective virus.
Insights
A specific mutation in HIV integrase (IN:M50I) impairs virus release and replication. However, a second mutation (IN:V151I) is required for this defect, revealing a dual-mutation requirement for defective HIV production.
Area of Science:
- Virology
- Molecular Biology
- Genetics
Background:
- A prior study identified an HIV-1 integrase (IN) mutation (IN:M50I) that severely impairs viral release and replication.
- Compensatory mutations in IN or RNaseH (RH) were found to restore infectivity, suggesting IN and RH involvement in HIV infectability.
Purpose of the Study:
- To investigate the prevalence of these HIV mutations in patients undergoing antiretroviral therapy.
- To understand the specific mutational combinations leading to defective HIV replication.
Main Methods:
- Population analysis of 529 plasma virus RNA sequences using MiSeq.
- Sequence comparison between defective and recombinant viruses.
- Western Blotting assays to assess viral protein processing.
Main Results:
- Fourteen HIV plasma samples harbored the IN:M50I mutation without compensatory changes.
- The IN:V151I mutation was identified in these viruses, known to be polymorphic.
- Reversion of IN:V151I to wild-type restored viral replication and Gag/GagPol processing.
Conclusions:
- The IN:M50I mutation alone does not produce replication-defective HIV.
- A combination of IN:M50I and IN:V151I mutations is necessary to generate defective HIV particles.
- This finding clarifies the specific genetic requirements for impaired HIV production and infectivity.
Related Concept Videos
Viral Mutations
Viral Recombination
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Intralumenal Vesicles and Multivesicular Bodies

